(Q51596264)

English

No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity.

scientific article published in March 1994

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

1 reference

based on heuristic

inferred from title

author name string

Visser M

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

Seidell JC

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

Koppeschaar HP

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

Smits P

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

publication date

1 March 1994

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

152-159

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Fluoxetine: a randomized clinical trial in the maintenance of weight loss

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Effect of fenfluramine on blood-lipids in man.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1994.TB00641.X

21 January 2018

Identifiers

10.1002/J.1550-8528.1994.TB00641.X

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/16353616

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51596264&oldid=1513570830"